This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Neonatal Abstinence Syndrome
Information about Neonatal Abstinence Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Neonatal Abstinence Syndrome
Most recent studies have shown that Neonatal Abstinence Syndrome shares some biological mechanisms with depressive-disorder, fatty-liver, hepatitis, hiv-infections, inflammation, influenza, liver-diseases, malignant-neoplasms, nonalcoholic-fatty-liver-disease, pain, pregnancy-complications, steatohepatitis, steatosis, substance-related-disorders, substance-withdrawal-syndrome, withdrawal-sign-or-symptom.
Among the many pathways, these few ones have gauged particular interests from scientists studying Neonatal Abstinence Syndrome, and have been seen in publications frequently: Aging, Cell Death, Cell Proliferation, Cognition, Conjugation, Drug Resistance, Excretion, Glycosylation, Immune Response, Innervation, Lactation, Localization, Locomotion, Nitrate Assimilation, Pathogenesis, Reflex, Secretion, Sensitization, Transport, Viral Replication
Quite a number of genes have been found to play important roles in Neonatal Abstinence Syndrome, such as AANAT, ALB, ASMT, BDNF, BRD2, CCK, ERMAP, INS, MAOA, NDUFB6, SLC17A5, TAC1, TFF2, TH, TNF, TNFSF14. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.